Medical/Pharmaceuticals
iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates
* Shows potent and rapid antibacterial activity against clinical isolates in Europe and Korea both * CDL200, a novel endolysin pipeline for the treatment of Clostridioides difficile Infection (CDI) * The world's first endolysin in capsule formulation to be administered orally BOSTON and SEO...
2022-07-12 10:06
2400
Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics
SALT LAKE CITY, July 11, 2022 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the acquisition of Dependable Plastics and creation of a new division -- Biomerics Interventional Medical Plastics (IMP) D...
2022-07-11 22:00
3008
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
* Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md. ,July 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-gene...
2022-07-11 20:10
4961
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report
* Aims to build an eco-friendly business environment and achieve net zero GHG emissions in its operations, moving towards 100% renewable energy. * Details new social contribution activities that strives to support the health of its local communities. * Requires commitment to the Supplier Cod...
2022-07-11 19:00
2866
SCG Cell Therapy Announces U.S FDA Clearance of Investigational New Drug Application for SCG101, SCG's Novel TCR-T Cell Therapy For Hepatitis B-related Liver Cancers
SINGAPORE, July 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG") announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for SCG101, an investigational T-cell receptor (TCR) T cell therapy for patients with hepati...
2022-07-11 13:34
3242
ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment
MELBOURNE, Australia, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed the final patient and completed recruitment into the Phase III pivotal study ZIRCON (Zirconium in Renal Cancer Oncology, NCT03849118) of its investiga...
2022-07-11 08:26
3385
Kevin Richardson appointed as CEO, Telix Americas
MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce thatKevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical mar...
2022-07-11 08:13
3656
CORDIS NAMES BRYAN LOO PRESIDENT OF ASIA-PACIFIC REGION
Seasoned medical technology leader tapped to maximize momentum in APAC MIAMI LAKES, Fla., July 8, 2022 /PRNewswire/ -- Cordis, a global leader in cardiovascular technologies, today announced thatBryan Loo will assume the role of President of theAsia-Pacific (APAC) region effective July 18, 2022. ...
2022-07-08 22:00
13241
Biotech Startup Noul Releases 2021 Sustainability Report
* Disclose achievement and improvement on economic, social, and environmental commitments * Contain corporate will to take sustainability as its management philosophy since its foundation * Write based on the GRI standards and self-disclose to the DART electronic disclosure system YONGIN, S...
2022-07-08 15:00
3050
HKUMed and CityU Scientists Discover Non-invasive Stimulation of the Eye for Depression and Dementia
HONG KONG, July 8, 2022 /PRNewswire/ -- A joint research team from Li Ka Shing Faculty of Medicine, TheUniversity of Hong Kong (HKUMed) and City University of Hong Kong (CityU) has discovered that electrical stimulation of the eye surface can alleviate depression-like symptoms and improve cogniti...
2022-07-08 12:30
4436
iGene Laboratory launches Monkeypox PCR test for the South East Asian region.
SINGAPORE, July 8, 2022 /PRNewswire/ -- iGene Laboratory, the molecular
diagnostics laboratory subsidiary of INEX Innovate Pte Ltd, announces the
launch of its research-use-only (RUO) polymerase chain reaction (PCR) Monkeypox
test in response to the recent outbreak of the virus.
2022-07-08 12:25
4083
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES
* NERLYNX® (neratinib) is approved by the Food and Drug Administration of the Philippines * Leading regional breast cancer oncologists say the availability of NERLYNX is a 'great step forward' for women inthe Philippines who have been diagnosed with HER2+ early-stage breast cancer * Five-y...
2022-07-08 09:28
2688
WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates
SHANGHAI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end-to-end bioconjugates services, and AbTis, a Korean biotechnology company dedicated to the development of antibody drug c...
2022-07-08 09:27
5335
A new study confirms: EMDR therapy can be done effectively online with remotEMDR
WORCESTER, England, July 8, 2022 /PRNewswire/ -- A first of its kind academic
research
2022-07-08 07:01
3235
Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle
* Exyte named as general contractor (EPCQ contract partner) * Project is part of the German government's program to prepare for future pandemics * Implementation in less than 24 months thanks to ExyCell® modular system * Lighthouse project for the strategic growth segment of Biopharma and L...
2022-07-08 06:58
5811
HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol
* Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX's Board of Directors as Non-Executive Director, bringing nearly 30 years of global drug development experience * Past achievements include approval of Augmentin BID for adults and children, plus foundational clinical development of bre...
2022-07-08 05:30
3646
Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine
* Insilico and its collaborators scoured massive datasets and found genes relevant to ALS through PandaOmics™, Insilico's proprietary AI-driven target identification engine. * 28 targets were identified from CNS and diMN samples; for 18 targets (64%), suppression moderately or strongly rescue...
2022-07-08 04:00
4122
United Imaging To Feature Leaders of Choice Program, Innovative Purchasing Models, and World's-First Equipment at AHRA in Phoenix
Leaders of Choice is the educational program United Imaging and AHRA Announced Jointly in May. HOUSTON, July 7, 2022 /PRNewswire/ -- United Imaging confirmed that its Houston-based U.S. leadership team will be on hand in Phoenix for the AHRA (Association for Medical Imaging Management) Annual Me...
2022-07-07 20:18
2463
SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972
NANJING, China, July 7, 2022 /PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharma in immunocytokines with full-set of capabilities from discovery to commercialization, announced that IAP0971 (PD1-IL15 immunocytokine) and IAE0972 (EGFR-IL10 immunocytokine...
2022-07-07 20:00
2353
Zhiyi Biotech Raised $45 Million in Series B Funding Round to Accelerate the Clinical Development of LBPs Pipelines
GUANGZHOU, China, July 7, 2022 /PRNewswire/ -- Recently, Zhiyi Biotech announced that it has raised$15 million in its B++ funding round. The funds will be used to boost the clinical development of the company's live biotherapeutic products (LBPs) pipelines. It's worth mentioning thatZhiyi has su...
2022-07-07 17:45
1939
Week's Top Stories
Most Reposted
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 293 media titles]
2026-10-22 22:35
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 276 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 270 media titles]
2026-10-22 11:55Carro Establishes Inaugural SGD450 Million Asset-Backed Securitisation Warehouse Facility
[Picked up by 267 media titles]
2026-10-22 11:00Most Read
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
16377
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
2026-10-19 13:18
12581
FinDev Canada provides a USD 60 million loan to Muangthai Capital to advance gender equality and private sector investment in Thailand
2026-10-17 00:54
12518
BUUU Group Limited Announces 10-for-1 Forward Share Split
2026-10-17 04:30
11969